Fuso Pharmaceutical Industries,Ltd.

$15.00

$0.48(-3.08%)

Fuso Pharmaceutical Industries,Ltd.

4538.T

$15.00

$0.48(-3.08%)

Fuso Pharmaceutical Industries,Ltd.

4538.T

JPX

$15.00

$0.48(-3.08%)

Chart

Upcoming Earnings

Next report date

May 13, 2026

Report period

Q2 2026

EPS Estimate

—

Revenue Estimate

—

Key stats

52-Week Range$15.00

$12.69

$16.27

Market capitalization

$130.05M

Dividend yield (indicated)

3.51%

Price to earnings Ratio (TTM)

10.25

Basic EPS (TTM)

$1.51

Net income (TTM)

$12.90M

Revenue (TTM)

$389.01M

Avg. volume

28.20K

Beta (1Y)

0.13

Employees

1.37K

Market capitalization

$130.05M

Dividend yield (indicated)

3.51%

Price to earnings Ratio (TTM)

10.25

Basic EPS (TTM)

$1.51

Net income (TTM)

$12.90M

Revenue (TTM)

$389.01M

Avg. volume

28.20K

Beta (1Y)

0.13

Employees

1.37K

Screener Quick Check

About Fuso Pharmaceutical Industries,Ltd.

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

CEO

Mikio Toda

Website

www.fuso-pharm.co.jp

Headquarters

1-7-10, Doshomachi, Osaka, 541-0045

IPO Date

2001-01-01

Identifiers

ISINJP3823600006

Description

Fuso Pharmaceutical Industries,Ltd. manufactures and sells pharmaceutical products in Japan. The company offers ethical drugs, such...

Related Stocks

Oncolys BioPharma Inc.

4588.T

$17.15Mkt Cap: $426.16M

Healthcare

Biotechnology

ISIN:JP3202170001

Pharma Foods International Co., Ltd.

2929.T

$4.20Mkt Cap: $121.40M

Healthcare

Drug Manufacturers - Specialty & Generic

ISIN:JP3802310007

Dividend Overview

Dividend yield (indicated)

3.51%

Dividend per share

$0.54annual

Payout ratio (Earnings)

—

Payout ratio (FCF)

—

Dividend growth streak

Dividend CAGR (3Y)

-15.7%

Dividend CAGR (5Y)

-5.6%

Dividend CAGR (10Y)

+18.9%

Dividend yield (indicated)

3.51%

Dividend per share

$0.54annual

Payout ratio (Earnings)

—

Payout ratio (FCF)

—

Dividend growth streak

Dividend CAGR (3Y)

-15.7%

Dividend CAGR (5Y)

-5.6%

Dividend CAGR (10Y)

+18.9%

Financials

Performance

Margin trends

Debt level and coverage

Earnings

Next: Q2 '26

Actual

Estimate

Earnings

Next: Q2 '26

Actual

Estimate

Performance

Margin trends

Debt level and coverage

Earnings

Next: Q2 '26

Actual

Estimate

Earnings

Next: Q2 '26

Actual

Estimate